Management of diabetic foot infection: A position paper

Canadian Journal of Infectious Diseases

Volumn 7, Issue 6, 1996, Pages

  Fong, I W ^a   Mandell, Lionel A ^b,i   Low, Donald ^c   Forward, Kevin ^d   Jewesson, Peter ^e   Turgeon, Pierre ^f   Nicolle, Lindsay ^g   Schlech III, Walter ^d   Gribble, Marie ^h  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e VANCOUVER GENERAL HOSPITAL   (Canada)

^f UNIVERSITY OF MONTREAL   (Canada)

^g UNIVERSITY OF MANITOBA   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ HENDERSON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFALEXIN; CEFAZOLIN; CEFOTETAN; CEFOXITIN; CEFTIZOXIME; CEFTRIAXONE; CEPHALOSPORIN; CILASTATIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; METRONIDAZOLE; OFLOXACIN; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; SULTAMICILLIN; TAZOBACTAM; TICARCILLIN; TIMENTIN;

DIABETIC FOOT; HUMAN; INFECTION; OSTEOMYELITIS; REVIEW;

EID: 0030450868     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lawee D, Csima A. Diabetes-related lower extremity amputations in Ontario: 1987-88 experience. Can J Public Health 1992;83:298-302.
2. Lipsky BA. Diabetic foot infections. Pathophysiology, diagnosis and treatment. Int J Dermatol 1991;30:560-2.
3. Louie TJ, Bartlett JC, Tally FP, Gorbach SL. Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med 1976;85:461-3.
4. Sapico FL, Canawati HN, Witte JL, et al. Quantitative aerobic and anaerobic bacteriology of infected diabetic feet. J Clin Microbiol 1980;12:413-20.
5. Wheat LJ, Allen SD, Henry M, et al. Diabetic foot infections. Bacteriologic analysis. Arch Intern Med 1986;146.-1935-40.
6. Sapico FL, Witte JL, Canawati HN, Montgomerie JZ, Bessman AN. The infected foot of diabetic patient: Quantitative microbiology and analysis of clinical features. Rev Infect Dis 1984;6(Suppl):S171-6.
7. Lipsky BA, Pecoraro RE, Larson SA, Hanley ME, Ahroni JH. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 1990;150:790-7.
8. Shults DW, Hunter GC, McIntyre KE, Parent FN, Piotrowski JJ, Bernhard VM. Value of radiographs and bone scans in determining the need for therapy in diabetic patients with foot ulcers. Am J Surg 1989;158:525-9.
9. Newman LG, Waller J, Palestro CJ, et al. Unsuspected osteomyelitis in diabetic foot ulcers diagnosis and monitoring by leucocyte scanning with indium in 111 oxyquinolone. JAMA 1991;266:1246-51.
10. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994;331:854-60.
11. Joseph WS. Treatment of lower extremity infections in diabetics. Drugs 1991;42:984-96.
12. Jones EW, Edwards R, Finch R, et al. A microbiological study of diabetic foot lesions. Diabet Med 1984;2:213-5.
13. Le Frock JL, Blais F, Schell RF, et al. Cefoxitin in the treatment of diabetic patients with lower extremity infections. Infect Surg 1983;2:361-74.
14. Hughes CE, Johnson CC, Bamberger DM, et al. Treatment and long term follow-up of foot infections in patients with diabetic or ischemia: A randomized, prospective, double-blind, comparison of cefoxitin and ceftizoxime. Clin Ther 1987;10(Suppl A):36-49.
15. Fong IW, Ledbetter WH, Vandenbroucke AC, Simbul M, Rahm V. Cipronoxacin concentrations in bone and muscle after oral dosing. Antimicrob Agents Chemother 1986;29:405-8.
16. Grayson ML, Gibbons GW, Habershaw GM, et al. Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin Infect Dis 1994;18:683-93.
17. Bamberger DM, Daus GP, Gerding DN. Osteomyelitis in the feet of diabetic patients: Long term results, prognostic factors and the role of antimicrobial and surgical therapy. Am J Med 1987;83:653-60.
18. Peterson LR, Lissack LM, Canter K, Fasching CE, Clabots C, Gerding DN. Therapy of lower extremity infections with ciprofloxoacin in patients with diabetes mellitus, peripheral vascular disease or both. Am J Med 1989;86:801-8.
19. The Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.